Recent presentations

SHM’s staff give presentations on several occasions throughout the year with findings from research and papers presented at conferences worldwide. The most recent presentations given in 2018 are listed below.

Presentations 2018

Oral presentation

Mortality and COD among HIV+ persons by ART experience in the Netherlands

van Sighem A.

Posters

PrEP for MSM can result in reductions in HIV transmission and can be cost-effective, even with a small decrease in condom use

Reitsema M, van Hoek AJ, Wallinga J, van Benthem B, van Sighem A, Schim van der Loeff M, Xiridou M.

 

Late presenters drive the non-ART cost of HIV-care

Popping S, Nichols BE,  van de Vijver DEAMC, Reiss P, van Sighem A, Brinkman K, Geerlings S, Boucher CAB, Verbon A, for the ATHENA HIV Observational Cohort.

 

Many introductions but little transmission of HIV-1 non-B subtypes amongst heterosexuals in the Netherlands

Bezemer D, Hall M, van Sighem A, Reiss P, Fraser C, Ratmann O.

 

Heterogeneity in pulmonary function indices by HIV status and cumulative smoking intensity among well-controlled HIV-infected persons compared to HIV-uninfected participants in the AGEHIV cohort

Verboeket SO , Wit  FW, Kirk GD, Drummond MB, van Steenwijk RP, van Zoest RA, Schim van der Loeff MF, Reiss P.

 

HCV treatment cascade in the Netherlands: DAA uptake varies by key population, effectiveness of HIV treatment and co-medication use

Smit C, Boerekamps A, Newsum AM, Arends JE, Richter C, Boender TS, Reiss P, Rijnders BJA, Brinkman K, van der Valk M, on behalf of the ATHENA national observational HIV cohort.

 

Incidence, timing and outcome of IRIS in relation to specific opportunistic infections - the ATHENA cohort study

Wijting IEA, Wit FWNM, Rokx C, van der Ende ME, Reiss P, Rijnders BJA, on behalf of the ATHENA national observational HIV cohort.

 

Non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy is associated with lower cell-associated HIV RNA and DNA levels as compared with therapy based on protease inhibitors

Pasternak AO, Kootstra N, Vroom J, Wit FWNM, de Bruin M, de Francesco D, Sabin C, Winston A, Prins JM, Reiss P, Berkhout B, on behalf of The Co-morBidity in Relation to Aids (COBRA) Collaboration and the MEMS Cohort Study.

 

Earlier HIV diagnosis among men who have sex with men in Amsterdam following interventions to increase awareness of early HIV infection

van Sighem A, de Bree G, Davidovich U, Zuilhof W, van Bijnen A, Verdult F, Dijkstra M, Heijman T, Hogewoning A, Op de Coul E,  van Bergen J, Schim van der Loeff M, Reiss P, HIV Elimination Amsterdam (H-TEAM) Initiative and the ATHENA National HIV Cohort.

 

The paediatric continuum of HIV care in the Netherlands: from diagnosis in childhood to viral suppression in adulthood.

Smit C, Wolfs T, Boender TS, van Rossum A, Reiss P, on behalf of the ATHENA observational cohort.

 

Substantial decline in virological failure after combination antiretroviral treatment (cART) initiation in treatment-naïve HIV-positive adults in the Netherlands from 1996 to 2016

Boender TS, Wit FWNM, van Sighem A, Brinkman K, van Nieuwkoop C, Wensing AMJ, Reiss P, on behalf of the ATHENA National Observational HIV Cohort.

 

Evaluating progress towards triple elimination of mother-to-child transmission of HIV, syphilis and hepatitis B in the Netherlands, 2012-2015

Visser M, van der Ploeg CPB, Smit C, Abbink F, Hukkelhoven CWPM, van Benthem BHB, Op de Coul ELM.

 

Does HIV-seroconversion affect the serum N-glycans profile, one possible biomarker of ageing? Insights from a longitudinal study

Pirazzini C, Garagnani P, Giampieri E, Sala C, Borelli V, Bacalini MG, de Francesco D, Sabin CA, Prins M, Wit FNMW, Kootstra NA, Libert C, Franceschi C, Reiss P, The Co-morBidity in Relation to AIDS (COBRA) Collaboration and the Amsterdam Cohort Studies on HIV.

 

Oral presentations

 

The ECDC HIV Modelling Tool: estimating the first stage in the HIV care continuum

van Sighem A.

Poster presentation

Cost-effectiveness of increased HIV testing among Dutch MSM

Mangen  MJ.

Oral presentation

Acute hepatitis C in people living with HIV: reporting and registration

Boender TS

Oral presentations

Models for case surveillance settings – ECDC model

van Sighem A and Quinten C.

 

Country case studies for incidence estimation - Netherlands

van Sighem A.

Oral presentation

Estimating the number of people living with undiagnosed HIV – the Netherlands

van Sighem A.

Oral presentation

HIV modelling

van Sighem A.

Oral presentation

Importance of investing in data collection to guide the response

van Sighem A.

Oral presentation

HIV-1 transmission dynamics in the Netherlands

Bezemer D.

Oral presentations


HCV treatment cascade: highest DAA uptake for MSM receiving cART
Colette Smit on behalf of ATHENA

Earlier HIV diagnosis in Amsterdam after implementation of an early HIV infection awareness campaign
Ard van Sighem on behalf of ATHENA

 

Poster presentations


Substantial decline in virological failure after combination antiretroviral treatment (cART) initiation in treatment-naive HIV-positive adults in the Netherlands from 1996 to 2016
Boender TS, on behalf of ATHENA

Acute hepatitis C infection among HIV-positive adults in the Netherlands: a capture-recapture analysis of two national databases
Boender TS

The paediatric continuum of HIV care in the Netherlands: from diagnosis in childhood to viral suppression in adulthood
Colette Smit on behalf of ATHENA

Oral presentations


Serious clinical outcomes in HIV-positive persons with chronic kidney disease (CKD)
Ryom L, on behalf of the DAD study 

Poster presentations


Determinants of cognitive function differ in a European and a Korean cohort
de Francesco D, Winston A, Choi YJ, van Zoest R, Underwood J, Schouten J, Ku NS, Kim WJ, Reiss P, Sabin C

Serum albumin as a long term predictor of serious non-AIDS events
Ronit A, Hatleberg CI, Ryom L, Bonnet F, El-Sadr WM, Reiss P, Weber R, Pradier C, de Wit S, Law M, D'Arminio Monforte A, Lundgren JD, Phillips A, Sabin C